REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pkc Spectehsbyt OOO (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pkc Spectehsbyt OOO Profile Updated: September 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Pkc Spectehsbyt OOO is a company in Russia, with a head office in Moscow. It operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on October 29, 2002. In its most recent financial highlights, the company reported a net sales revenue drop of 5.33% in 2023. Its total assets grew by 8.21% over the same period. In 2023, Pkc Spectehsbyt OOO’s net profit margin decreased by 2.71%.

Headquarters
Novoyasenevskii, 6, 1 2
Moscow; Moscow; Postal Code: 117574

Contact Details: Purchase the Pkc Spectehsbyt OOO report to view the information.

Website: http://sts-med.ru

Basic Information
Outstanding Shares:
Purchase the Pkc Spectehsbyt OOO report to view the information.
Registered Capital:
Purchase the Pkc Spectehsbyt OOO report to view the information.
Incorporation Date:
October 29, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
28.25%
Purchase this report to view the information.
21.75%
Purchase this report to view the information.
17.5%
Purchase this report to view the information.
17.5%
Purchase this report to view the information.
15%
Subsidiaries
Biglainstroy ZAO
25%
Company Performance
Financial values in the chart are available after Pkc Spectehsbyt OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-5.33%▼
Total operating revenue
-5.33%▼
Operating profit (EBIT)
-40.18%▼
Net Profit (Loss) for the Period
-39.26%▼
Total assets
8.21%▲
Total equity
7.42%▲
Operating Profit Margin (ROS)
-3.63%▼
Net Profit Margin
-2.71%▼
Return on Equity (ROE)
-11.47%▼
Quick Ratio
0.39%▲
Cash Ratio
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo